| Prostate cancer–associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4 X Dai, W Gan, X Li, S Wang, W Zhang, L Huang, S Liu, Q Zhong, J Guo, ... Nature medicine 23 (9), 1063-1071, 2017 | 291 | 2017 |
| TRIM24 is an oncogenic transcriptional activator in prostate cancer AC Groner, L Cato, J de Tribolet-Hardy, T Bernasocchi, H Janouskova, ... Cancer cell 29 (6), 846-858, 2016 | 256 | 2016 |
| High‐throughput proteomic analysis of FFPE tissue samples facilitates tumor stratification Y Zhu, T Weiss, Q Zhang, R Sun, B Wang, X Yi, Z Wu, H Gao, X Cai, ... Molecular oncology 13 (11), 2305-2328, 2019 | 124 | 2019 |
| Machine learning for multi-omics data integration in cancer Z Cai, RC Poulos, J Liu, Q Zhong Iscience 25 (2), 2022 | 107 | 2022 |
| Strategies to enable large-scale proteomics for reproducible research RC Poulos, PG Hains, R Shah, N Lucas, D Xavier, SS Manda, A Anees, ... Nature communications 11 (1), 3793, 2020 | 102 | 2020 |
| Pan-cancer proteomic map of 949 human cell lines E Gonçalves, RC Poulos, Z Cai, S Barthorpe, SS Manda, N Lucas, A Beck, ... Cancer Cell 40 (8), 835-849. e8, 2022 | 83 | 2022 |
| Unsupervised modeling of cell morphology dynamics for time-lapse microscopy Q Zhong, AG Busetto, JP Fededa, JM Buhmann, DW Gerlich Nature Methods 9 (7), 711-713, 2012 | 79 | 2012 |
| Quantitative proteome landscape of the NCI-60 cancer cell lines T Guo, A Luna, VN Rajapakse, CC Koh, Z Wu, W Liu, Y Sun, H Gao, ... Iscience 21, 664-680, 2019 | 56* | 2019 |
| Cytology smears as excellent starting material for next‐generation sequencing‐based molecular testing of patients with adenocarcinoma of the lung NP Velizheva, MP Rechsteiner, CE Wong, Q Zhong, M Rössle, B Bode, ... Cancer cytopathology 125 (1), 30-40, 2017 | 56 | 2017 |
| Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer C Poyet, L Buser, F Roudnicky, M Detmar, T Hermanns, D Mannhard, ... Journal of clinical pathology 68 (10), 819-824, 2015 | 53 | 2015 |
| Multi-region proteome analysis quantifies spatial heterogeneity of prostate tissue biomarkers T Guo, L Li, Q Zhong, NJ Rupp, K Charmpi, CE Wong, U Wagner, ... Life science alliance 1 (2), 2018 | 52 | 2018 |
| Comparison of the proliferation and differentiation potential of human urine‐, placenta decidua basalis‐, and bone marrow‐derived stem cells C Wu, L Chen, Y Huang, Y Huang, O Parolini, Q Zhong, X Tian, L Deng Stem Cells International 2018 (1), 7131532, 2018 | 51 | 2018 |
| Comparative analysis of mRNA and protein degradation in prostate tissues indicates high stability of proteins W Shao, T Guo, NC Toussaint, P Xue, U Wagner, L Li, K Charmpi, Y Zhu, ... Nature communications 10 (1), 2524, 2019 | 42 | 2019 |
| KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation K Ikenberg, N Valtcheva, S Brandt, Q Zhong, CE Wong, A Noske, ... The Journal of pathology 234 (2), 239-252, 2014 | 41 | 2014 |
| Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity Q Zhong, JH Rüschoff, T Guo, M Gabrani, PJ Schüffler, M Rechsteiner, ... Scientific reports 6 (1), 24146, 2016 | 34 | 2016 |
| MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients M Lukamowicz-Rajska, C Mittmann, M Prummer, Q Zhong, J Bedke, ... Oncotarget 7 (48), 78433, 2016 | 32 | 2016 |
| Addressing the challenges of high‐throughput cancer tissue proteomics for clinical application: proCan B Tully, RL Balleine, PG Hains, Q Zhong, RR Reddel, PJ Robinson Proteomics 19 (21-22), 1900109, 2019 | 30 | 2019 |
| A curated collection of tissue microarray images and clinical outcome data of prostate cancer patients Q Zhong, T Guo, M Rechsteiner, JH Rüschoff, N Rupp, C Fankhauser, ... Scientific data 4 (1), 1-9, 2017 | 25 | 2017 |
| Application of nanosecond laser photolysis protein footprinting to study EGFR activation by EGF in cells Y Zhu, A Serra, T Guo, JE Park, Q Zhong, SK Sze Journal of proteome research 16 (6), 2282-2293, 2017 | 24 | 2017 |
| Value of postmortem studies in deceased neonatal and pediatric intensive care unit patients R Widmann, R Caduff, L Giudici, Q Zhong, A Vogetseder, R Arlettaz, ... Virchows Archiv 470, 217-223, 2017 | 24 | 2017 |
Peter WildFull Professor of Pathology, Director Dr. Senckenberg Institute of Pathology, Univ. Hospital在 kgu.de 的电子邮件经过验证
